Clare Rawlinson Malone
About Clare Rawlinson Malone
Clare Rawlinson Malone is the Associate Scientific Director at Bristol Myers Squibb, a Visiting Research Fellow at the University of Reading, and a Locum Pharmacist. She has a robust background in drug product development and has implemented various management systems and training programs.
Current Roles and Responsibilities
Clare Rawlinson Malone currently holds the position of Associate Scientific Director at Bristol Myers Squibb in Moreton, England, United Kingdom. Additionally, she serves as a Visiting Research Fellow at the University of Reading in Reading, United Kingdom. She is also working as a self-employed Locum Pharmacist. These roles showcase her diverse professional engagements and expertise in scientific research and clinical practice.
Workflow and Training Systems Implementation
In her capacity as Associate Scientific Director, Clare Rawlinson Malone has implemented management systems to optimize workflow and training processes at her organization. Part of her responsibilities included designing and delivering new Non-GXP laboratory facilities, which underscores her proficiency in establishing advanced research environments that meet non-Good Laboratory Practice (non-GLP) guidelines.
Development of Novel Dissolution Methodologies
Clare Rawlinson Malone has a strong technical background in pharmaceutical sciences, demonstrated through her development of novel dissolution methodologies. This facet of her expertise contributes significantly to the field of drug product development by addressing crucial aspects of how new pharmaceutical formulations dissolve and deliver active ingredients effectively.
Training and Mentoring Programs
A notable aspect of Clare Rawlinson Malone's professional contributions includes delivering a comprehensive program of training opportunities. These training initiatives covered diverse topics such as TED talks, growth mindset, unconscious bias, and adapting working styles. Moreover, she was instrumental in establishing a peer mentoring program at her company, reflecting her commitment to fostering professional development and a collaborative work environment.
Drug Product Development Expertise
Previously, Clare Rawlinson Malone led a matrix drug product development team, focusing on enabling formulations. Her work included the formulation of Spray Dried Amorphous Dispersions (SDD) and Cocrystals. Her expertise extends to pilot-scale work, where she has addressed challenges related to formulation flow, compression, segregation, stability, disintegration, and process-induced changes, contributing significantly to advancements in drug product development.